Filing Details
- Accession Number:
- 0001209191-20-005353
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-29 16:05:07
- Reporting Period:
- 2020-01-27
- Accepted Time:
- 2020-01-29 16:05:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1532346 | Atreca Inc. | BCEL | Pharmaceutical Preparations (2834) | 273723255 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1774119 | Guy Cavet | C/O Atreca, Inc., 450 East Jamie Court South San Francisco CA 94080 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2020-01-27 | 10,000 | $20.00 | 92,758 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2019.
Billionaire Hedge Funds
